AbbVie has toppled Sanofi and Regeneron as the biggest drug ad spender across the pharmaceutical industry in 2023 with a major victory for its next-gen immunology blockbuster Skyrizi. In 2022, the ...
Navitus released its eighth annual 2023 Drug Trend Report, which shows a year-over-year trend of 6.8% within the commercial book of business. Twenty nine percent of Navitus commercial clients paid ...
Prescription drug spending grew by 13.5% in 2023, but drug cost inflation was lower than the CPI. The United States spent $772.5 billion on prescription drugs in 2023, a 13.5% increase from 2022, ...
Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! Drugmakers spent big on advertisements for weight loss and diabetes treatments last ...
MADISON, Wis.--(BUSINESS WIRE)--Navitus, an innovative pharmacy benefit manager (PBM), released its 2023 Drug Trend Report today. The eighth annual report shows a year-over-year trend of 6.8% within ...
Surescripts saw a nearly 10% increase in patient intelligence sharing in 2023, with nearly 24 billion exchanges of patient clinical and benefit information, connecting 2.14 million care providers and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results